Dcpart mcllt of Dermato logy. Ca liforni a Coll ege of Medi cine, Uni ve rsity of Californi a. Ir vine, Ir vine, C alifornia, U. S. A. D irect a u toradiog ra phi c identifi cation of the epidermal g row th fraction (G F) req uires the delivery o f triti a ted th ymidine WHJdThd) to the s kin during the time interval of an entire cell cy cl e. The GF in n orma l hum an epide rmi s has n ot bee n directl y mea s ured using this techniqu e because th e sys te mi c infusion of radioa c tive j 3 H jdT hd in beni g n skin condition s is precluded b y e thi c:tl conside ra tions. Studies w ere und e rtake n to assess the fe as ibility of meas uring the e pid e rmal GF in vivo by th e topical d eli ve r y ofi 3 H]dThd.
The optim :tl p e netra tion of [ 3 HldThd, with respect to th e con centration of A zo ne over a range of0-4%, was ac hi eved at 2 %. Durin g the initi al 24 h fo ll owing a sin g le topica l a ppli ca tion of j 3 H]dThd to h airless mice the labelin g inc reas ed lin ea rly with time . In vivo s tudie in hairle ss mice produced a GF of 95% b y both co ntinuou s sys te mi c A zone ve hi cles induced e piderm al h y perplas i3 w hi c h was minimized b y lowe rin g the Azone co n centration a nd b y dec reasin g the frequ e n cy of 3ppli cations from 24 to 48 h. -
--------------------------------------
T he g row th fracti o n (G F) is an impo rtant kineti c parameter in experim entall y definin g th e rate o f ep idcrnlJ! cell repro du cti o n. T he GF of :t cell po pulati o n is by definition th at fract io n of cell s actua ll y in the pro cess of pro liferatio n Jll . Th e traditi01nl m ethod fo r measurin g G Fs requires a cont inu o us systemi c in fus io n of triti~ted th y midin e WHidThd ) and sequenti al bio ps ies for autoradi ographi c ana lysis to detect cell s sy nth esizin g ON A durin g th e J·' H ldThd infu sio n . When th e percenta ge of labeled basal cell s attain s a plateau, essenti all y all ac ti vel y proliferatin g cells have been labeled. The heig ht of this platea u, expressed as the percenta ge o f labeled cell s. is an estimate o f the G F for th e cell popul ation under investi ga tion.
Systemic infus io n o f J 3 HidThd has been used to mea sure GF in anim als J2 1 and termina l ca nce r p::Hients J3 1. H owe ver ethi cal con siderations preclude syste mi c 1 3 1-1 ldT hd infu sio n in humans w ith beni g n skin conditi o ns. Local intradermal injection o f [ 3 1 -lldThd g ive n sequ entiall y o ver the entire cell cy cle g reatl y redu ces the dosa ge of radi oactive labeled dru g needed to measure cell cycle tim e (T c). T he bri cfTc in a psoriati c p laque (36 h) [4j permits the usc of multiple intraderm al 1.1 1-1 ld T hd inj ection s in Manuscript rec~i ve d April I, l'iHS; accepted for publi ca tion October . Howev er, in hea lth y human skin therepea ted traum a of multiple inj ections into the sa m e site during the no rmal 13-d ay cell cycle wo uld more than likel y produ ce a proliferative ''woundin g" res po nse. and th erefo re an ina ccurate m easure m ellt of GF. Topica l delivery of J 3 H ldThd sho uld minimize the sys temi c exposure of thi s radioa cti ve compo und and also avoid the trauma of re pea ted inj ections. T he present stud y was th erefore undertaken to assess the fea sibility of usin g topical de- 
In Vitro Studies
In vit ro studi es used fu ll-thi ckness excised norma l hum an abdo min al autopsy skin , stored at -20°C , th awed, and placed o n glass diffu sio n chambers. A topical dose of10 J.LC i of [ p i r a tion. The radi oactivit y of thi s soluti o n wa s measured usin g a scintill a tion co unter to obta m the tota l cpm th at had diffu sed IntO the r eser voir between tim e points. T he amo unt o f resid ual [ 3 H]dThd in th e d ermi s < lt th e conclusio n of a percutaneou s absorpti o n experiment w as determin ed by remov in g the epid ermis, di gestin g the der m al portion of the pun ch bi o psy in N aOH , :md m eas urin g the r adioac tivit y.
In Vivo Studies In th e in vivo ex perim ents 20 p.C i o f[
3 H]dT hd in 50 fLl of ve hi cle were applied to the backs of hairless mi ce . Funnel-shaped co llars were pb ced o n the mi ce to prevent them fro m ingesti n g the appli ed IJ H] dT hd . B iopsies from the ba ck and abdo m en we re processed fo r aut orad iog rap h y. Autoradi og raphi c a n a l ys is invol ved tiss ue fi xa ti o n of bi o psi es in 10% buffered fo rInalin and e mbedd in g in paraffin ; 6 p.m-thi ck tiss ue secti o ns on slid es were dipped in Kodak NTB2 em ul sio n and developed after 8 wee ks. T he number of bbeled basal cel ls per 1000 basa l ce lls was co unted under o il imm ersio n and this fr ac ti on repo rted as the l abelin g index (LI).
To d etermin e th e effects of a sin g le app lica ti on of ( 3 H]dThd , SA = 25 C i/ mm o l, on epiderma l LI , g roups of 2 mi ce were sacr i ficed and biopsied sequ entially at times 3, 6, 12, and 24 h. To co m pare th e effect o n epidermal Ll of va ryin g the SA of th e top ica li 3 H]dThd , 2 g ro ups of 15 mi ce received a sin g le appli cati o n of [3H]dThd , wi th SA of either 25 o r 47 C i/ mmol , at tim e (t) = 0 . Three mice fr o m each g ro up were sacrifi ced and biops ied dail y on days 1-5 .
To co mpare topi cal vs sys temi c delive ry of I 3 H idThd, SA = 25 C i/ mm ol , o ver a 1-week peri od , o ne g ro up of 14 mi ce was given twi ce d ail y (8 AM and 5 PM) to pi cal applicatio ns, with sub g ro ups of 2 mi ce bein g sacrifi ced and biopsied daily (6 PM ). A seco nd g ro u p of 3 mi ce was imp lanted w ith intraperito nea l osmotic diffusi on pumps conta inin g I 3 H]dT hd (S A = 25 C i/ mm ol) w ruc h diffu sed co ntinu o usly into the systemi c circul ation. Dorsa l sk in was bi o psied o n da ys 'I, 2, 4, 5, 6, and 7. On da y 7 an additio n al biopsy was tJ ken fr o m the abd o men of ea ch mo use . Epid ern1al labelin g indi ces were co mpared afte r o nce-dai ly and o n ce-ever y-o ther-da y dose sched ules using topica l I. >H]dTh d (SA = 47 C i/ mm o l) . In o m: gro up daily dosages were app lied at t = O, I , 2. 3, and 4 days; another g ro up was treated everyoth e r-d ay, with dosages applied at t = 0, 2, and 4 da ys . Each g roup contain ed 15 mi ce. Subg ro ups were sacrifi ced and bi o psicd at l eas t 24 h afte r the m os t recen t dose, on d:~ys 1-5.
H y perproliferative effects o f the ve hicle and its vJrio us co nipo nen ts we re e~xa mined w ith 5 treatment g ro ups each of w hi ch received o ne o t th e fo ll ow mg top ical ap ph ca no ns: no treatment (contro l); wate r alo ne; iso propano l and water ( I : I); Azo ne (2%) and wa ter; o r the stand ard ve hi cle of A zo ne (2% ), iso pro pano l (49o/o), and wa ter (49%,). 
RES ULTS
In Vitro Studies T he in vitro penetrati on of I 3 H ]dThd was de te rmin ed in 4 different ve hi cles (Fig l ) . Th e ve hicle chosen o n the bas is of m aximum cumul ati ve penetrati o n ove r 48 h, co nsisted of 2 % A zone , 49 % isop ro panol, and 49 % water. At the end o f the 48-h ex perim ent 2.8% of th e app lied dose had accumubted in the aqueo us rese rvoi r benea th th e skin and an additio nal 2.2% o f the applied dose remain ed in the dermis. T hus an es tim :lted 5% of th e ap plied In Vivo Studies A tim e-depen dent lin ea rl y in c re:~se d labelin g of th e do rsa l skin over 24 h is evident after a sin g le topi ca l appli ca ti on of I 3 H . IdT hd in the 2% Azonc ve hi cle (Fig 2) . T he labeling is co nfined to th e lowe r row of epiderm al cell s. T he few labeled cells at sites d istan t fro m th e site of i 3 H ldThd appli cati o n wa s ev idence to r min im al systemic abso rpti o n (Fig 3) . Doublin g the SA of th e topi cal [ 3 H]dThd (S A = 25-47 C i/ mmol) signifi cantl y in creased th e autoradiographi c labelin g intensity o f indi vidu al cell s w ith to pi call y app lied [ 3 H]dThd withou t chan g in g the Li s. N o epiderm al labelin g was ev iden t with topica l appliGition of [.IH]dThd in the isopro panol-water vehicle wi th out Azone.
Co mparin g t o~i cJ I and syste mic deli ve ry usin g an intraperito nea l os moti c d itfusio n pu mp o fi · 1 H JdT hd , the Li s both achieved a similar plateau o f85:-95 %, sugges tin g simil ar G Fs (Fig 4) . For any g iven Ll , the intensit y o f AR labelin g in ter m s of number of grain s per cell was g re:n er fo r sys temi c tlun fo r ropi c:II delivery of (. >1-l ldThd. After 4 days of continuo us systemi c i 3 H]dThd labelin g by intrape ri to nea l os m otic d iffusio n pump , an 85-95% do rsa l ski n Ll was achieved. In con trast. afte r o nl y 2 da ys of local 1-' HidThd app li catio n. a Ll of 95'Yo was meas ured in topi call y treated do rsa l skin. In these ex perim ents, ep iderm al hyperplasia first beca me apparent 24-36 h after a sin g le ap pli ca ti on of the Azone-co ntainin g ve hicle. Vehi cle-indu ced epider mal h yperpl as ia is pres umabl y res pon sible fo r thi s accelerated labelin g. In the topicall y treated mi ce b y da y 2, the abd o minal skin h:1s :1 Ll of less than 20% . O n the day 7, w hen do rsa l and abd o min al skin ha ve simil ar Li s, th e rel ative intensity o f labelin g, based on g rain co un ts per cell , is approxi mately 5-to ld g reater in dorsa l skin co mpared with abdo minal skin (Fi g 3) . In contrast, the systemi c de livery of I. 1H]d T hd resulted in labelin g the abdo men and ba ck w ith eq ual in tens ity and percentage, and there was no ev idence of h yperplas ia in the dorsa l epid ermis (Fig 5) .
Appl yin g topi cal [ 3 H]dThd o nce da il y o r every other day gives an eq ual de g ree of epidernul labelin g. But dail y app licati on was associated w ith 3 sli g htl y g reater deg ree of ve hi cle-indu ced epidermal h ypcrproliferation co mpared w ith every-other-day trea t- m ent. Of th e 3 co mpo ne nts co mpris in g t he ve hicl e o nl y A zo nc w;1s fo und to co ntribute to the indu cti o n of ep ide rm al h y pcrprolife rJt io n ( Table 1) .
D ISC u SS IO N
C ell kineti c m o dels provide a co n ceptu al framework fo r b o th th e stud y of pro li feration co ntro l m ech J nis m s J nd th e rati o nal d esig n of therap y fo r diseases, s uc h as ca n ce r a nd pso ria sis 15, 6 1. A cco rdin g to classic cell kin e ti c theo ry, th ose cell s in th e ~e rminati ve basa l laye r not ac tivel y pro liferatin g (Go) a rc either : ( I) prolife rati n g keratino cytcs th a t arc te mp o ra ril y in a res tin g pha se; (2) nonkerat inocy te s (e.g., m clan cy tes); o r (3) postm ito ti c diffcremiatcd ke ratin ocy tes s till re m ainin g in the b asJ ! byer. The term ,~1'011Jii1 Ji'actic>ll rep rese nts th e perce nta ge of < lCti vcl y pro li feratin g cell s in th e populatio n act u all y bein g studi ed. In m os t human so lid tum o rs that have bee n in vestiga ted, there a rc always cell s tlut arc n ever labeled b y co ntinuo us l-' 1--1 \dT hd infu sio n , w ith th e m ajo rit y of tumors lu ving a G F 30-70'Yo 15,7 1. In vivo d a ta fr o m lo n g-te rm 1 3 1--1 ldThd infusio n s tudi es in mi ·c and sw in e arc co nsistent w it h an epidc rmJI GF app rox im Jt in g 85-100% \2 \.
In th e case o f pso ri as is there is ge ne ral a~r ec mcnt th a t the GF in th e pro liferat ive com part m ent o f lcsio n J I skin a pproxim ates 100% \2,8 1. In co ntrast, t he GF in no rm al o r uninv o lved skin Iu s been estim ated to ran ge from 60-100% \2,<J \. Estim ating th e num e ri ca l va lu e o f CF is a necessary pre requi site to ca lculatin g the cell cycle duration w h e n the stage-durati o n m et ho d of ana lys is is used , i.e .. T c is ca lculated fr o m the experim enta l va lu es fo r len g th of S ph ase , Ll , and G F 121 . T he d etermin a ti o n of GF in no rm al sk in is c riti ca l to und e rs tandin g the pro li fe rati ve defec t in pso ria sis. lf the true GF in norma l s kin is IUO'Yo, then pso ri atic h y perp ro lifcratio n is the res ult of a vas t ly accc.: kratc d rate of cell divis io n. On th e o the r hand, if th e G F in no rm al s kin is low , e.g. , 20'Yo , w it h a quiesce n t Go frac ti o n of 8() %, th en the T c of no rma l cell s mi g ht approx im ate the ra pid rate seen in pso riati c cell s. Hen ce, the tra nsiti o n fr o m uninv o lved to lcs io nal s kin in pso ria sis wou ld res ult in brgc part from th e rec ruitm ent of the e ntire quiescent cell p o pulat~on Ill Go 111to the prolife ra~I ve GF. T h e c urre nt infornunon 1nd1 cates , h owever , that th e G l-of n o rma l s kin is at leas t 60% and t hus t he Tc o f eac h cell po pul a ti o n must b e s ubsta ntiall y d iffe re nt f2,9 l.
T h e prese nt in ves ti g ation _ is prelimin a r y to ex plo rin g th_e usc of topica l f 3 H ldThd pre pa rations fo r dete rmm111 g th e C F o t no rma l hum a n skin in v ivo. W e have found that a co mbmati o n of A zo n e, is o pro panol, and water (2 : 49: 49) prov ides effecti ve [3 H]dThd percutan eo us pe netration thro u g h excised human abdom in a l s kin . A zone was 1ncluded 111 th ese ve hicle s tudies because of r ecent re ports desc ribin g its pen e tratio n e nhan cin g e ffec ts 11 0 lIn rhe present study veh icles co ntainin g A_ zo n e ~rodu ced cutaneo u s irritation and loca l a ug m e ntatio n ot L l. 1 h1 s effect was mini mi zed b y lowerin g th e A zo ne co nce ntratio n ;md decreas in g the fr equ e n cy of topi cal app li catio n from d ail y to eve r y other day. Previous s tudi es have s hown th :u Azo nc IS extreme ly trntatm g ' Trea tm ents appli ed to do rSJ I "' " " '" s ki11 :11 t = ll. 11. 14 h: l 'llldThd i11j cCicd i. p . a t t = 48 h .
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to rodent ski n , whereas in human s the irrita n cy is mu c h less, co mp a ra ble to minera l o il and eve n less irrita tin g than V ase li ne Intensive C are Lo tion. t T he re arc n o publis hed rep o rts of Azoneindu ced h y perpla sia in human s kin.
The curre n t use of intraderma ii 3 H.JdThd is g en e ra ll y 5 J.LC i/ 0.1 ml inj ecti o ns up to a m axi mum of 20 inj ecti o ns o r a tota l of I 00 J.LC i/s ubjc c t. Wit h th e topi cal a pproach describ ed he re, 5% pe ne trati o n ra te of20 J.L C i app li ed wou ld g ive 1 J.LC i absorption aft e r eac h topi ca l a ppli cation. T he cumulati ve dose o f a 10-to 20-d ay expe rim ent wo uld be we ll below a 100 J.LC i total int rade rm al dosa ge .
O ur in vivo expe riments revea led t lut withi n a t least th e firs t 24 h after a sin g le app li ca ti o n , th e re is a linea rl y in creas in g L l. In the m o u se m ode l it appea rs th at t h e re is a rese rvoi r ctTcct with ( 3 1-!JdThd pen e tra ti o n over 24 h. To avoid ve hi cle-indu ced h ype rpla sia, the optimal approa c h in human skin m ay be to ap pl y a [ 
